UCB Brings Neupro(R) Back To All Patients In Europe

UCB announced that Neupro® (rotigotine transdermal patch) can now be prescribed to all patients with idiopathic Parkinson’s disease in Europe and is newly available for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS) in adults. This follows the decision of the European Commission to lift treatment restrictions on Neupro® in line with the recommendation of the European Medicines Agency (EMEA), issued on 29 May 2009.

More: continued here

Filed under: Neurology / Neuroscience on June 29th, 2009